The forkhead transcription factor Foxo1 bridges the JNK pathway and the transcription factor PDX-1 through its

Dan Kawamori1, Hideaki Kaneto, Yoshihisa Nakatani

  • 1Department of Internal Medicine and Therapeutics (A8), Osaka University Graduate School of Medicine, Suita City, Japan.

Insights

Oxidative stress and JNK signaling disrupt pancreatic beta-cell function by affecting PDX-1. The study reveals Foxo1 acts as a key mediator in this process, influencing PDX-1 translocation.

Area of Science:

  • Cell Biology
  • Molecular Biology
  • Endocrinology

Background:

  • Oxidative stress and c-Jun N-terminal kinase (JNK) pathway activation are known to cause pancreatic beta-cell dysfunction.
  • This dysfunction is linked to the nucleocytoplasmic translocation of the pancreatic transcription factor PDX-1.

Purpose of the Study:

  • To investigate the role of the forkhead transcription factor Foxo1/FKHR as a mediator between the JNK pathway and PDX-1.
  • To elucidate the mechanisms underlying PDX-1 translocation under oxidative stress.

Main Methods:

  • Utilized the pancreatic beta-cell line HIT-T15.
  • Manipulated JNK pathway activity (overexpression and suppression).
  • Assessed intracellular localization of Foxo1 and PDX-1.
  • Employed adenovirus-mediated gene transfer and small interfering RNA (siRNA) for Foxo1 manipulation.
  • Measured Akt activity and Foxo1 phosphorylation.

Main Results:

  • Oxidative stress induced nuclear localization of Foxo1 in HIT-T15 cells.
  • JNK pathway activation mimicked and mediated oxidative stress-induced Foxo1 nuclear translocation.
  • Akt activity decreased, leading to reduced Foxo1 phosphorylation under oxidative stress or JNK activation.
  • Foxo1 overexpression reduced nuclear PDX-1, while Foxo1 suppression maintained PDX-1 nuclear expression under oxidative stress.

Conclusions:

  • Foxo1 acts as a crucial mediator in the nucleocytoplasmic translocation of PDX-1.
  • The JNK pathway and oxidative stress influence PDX-1 translocation via Foxo1.
  • Findings provide insights into the molecular mechanisms of pancreatic beta-cell dysfunction.

Related Concept Videos

NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
Master Transcription Regulators02:23

Master Transcription Regulators

Master transcription regulators are regulatory proteins that are predominantly responsible for regulating the expression of multiple genes. Often these genes work in concert to drive a  complex process. Activation of a master transcription regulator can lead to a cascade of transcriptional activation necessary for that outcome. These regulators can directly bind to the regulatory sequences of the various genes involved, or they can indirectly regulate transcription by binding to regulatory...
Master Transcription Regulators02:23

Master Transcription Regulators

Master transcription regulators are regulatory proteins that are predominantly responsible for regulating the expression of multiple genes. Often these genes work in concert to drive a  complex process. Activation of a master transcription regulator can lead to a cascade of transcriptional activation necessary for that outcome. These regulators can directly bind to the regulatory sequences of the various genes involved, or they can indirectly regulate transcription by binding to regulatory...
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
NF-kB-dependent Signaling Pathway02:26

NF-kB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...